chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: scared to receive the 2nd vaccine; diarrhea; chills; nausea; fever; Can't sleep at night; no appetite; shortness of breath; throat was hurting; trembling; shaking; anxiety; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Can't sleep at night), DECREASED APPETITE (no appetite), DYSPNOEA (shortness of breath), OROPHARYNGEAL PAIN (throat was hurting) and TREMOR (trembling) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Palpitation and Kidney transplant. Concurrent medical conditions included Blood pressure high. Concomitant products included MYCOPHENOLATE MOFETIL (MYCOPHENOLATE), NIFEDIPINE, PREDNISONE, ROSUVASTATIN, VALSARTAN and TACROLIMUS for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced INSOMNIA (Can't sleep at night), DECREASED APPETITE (no appetite), DYSPNOEA (shortness of breath), OROPHARYNGEAL PAIN (throat was hurting), TREMOR (trembling), TREMOR (shaking), ANXIETY (anxiety), DIARRHOEA (diarrhea), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever). On 24-Mar-2021, the patient experienced FEAR (scared to receive the 2nd vaccine). At the time of the report, INSOMNIA (Can't sleep at night), DECREASED APPETITE (no appetite), DYSPNOEA (shortness of breath), OROPHARYNGEAL PAIN (throat was hurting), TREMOR (trembling), TREMOR (shaking), ANXIETY (anxiety), FEAR (scared to receive the 2nd vaccine), DIARRHOEA (diarrhea), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Burning feet syndrome, Burning sensation, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain disorder got worst), BURNING FEET SYNDROME (feet burns/ my feet felt like they were on fire) and BURNING SENSATION (nerves of arms burn/ burning in my feet and up to my knees) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M2DA) for COVID-19 vaccination. The patient's past medical history included Pitting edema (Patient stated that she has had problems of pedal and ankle pitting edema.). Concurrent medical conditions included Arachnoiditis adhesive chronic. Concomitant products included MORPHINE, AMLODIPINE, FUROSEMIDE, METILPREDNISOLONE, ATORVASTATIN, LEVOTHYROXINE, CALCIUM CITRATE, CALCIUM CITRATE MALATE, MAGNESIUM (OSSOPAN MCM), VITAMIN B COMPLEX, VITAMIN D3, DOCUSATE SODIUM, CURCUMA LONGA (TURMERIC CURCUMIN [CURCUMA LONGA]), FISH OIL and PREGNENOLONE for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN (pain disorder got worst), BURNING FEET SYNDROME (feet burns/ my feet felt like they were on fire) and BURNING SENSATION (nerves of arms burn/ burning in my feet and up to my knees). At the time of the report, PAIN (pain disorder got worst), BURNING FEET SYNDROME (feet burns/ my feet felt like they were on fire) and BURNING SENSATION (nerves of arms burn/ burning in my feet and up to my knees) outcome was unknown.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Alanine aminotransferase increased: high (High) Patient stated that her test results showed slight elevation of ALT. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment included strong pain medicine. Patient was scheduled to get the second dose of vaccine on 26-Mar-2021. Patient was on diabetic controlled diet and had neuropathy problems in relation with her arachnoiditis. patient was also stated that the event burning sensation in  feet to below knees has been continuing since receiving the first dose of vaccine. Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: follow-up received and Updated lab data. Added medical history (pitting edema).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site cyst, Vaccination site warmth
Clinical narrative: Arm feels like its burning, hot; hard knot, seems like its getting bigger Spreading down to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm feels like its burning, hot) and INJECTION SITE CYST (hard knot, seems like its getting bigger Spreading down to her elbow) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included FUROSEMIDE, AMLODIPINE, LISINOPRIL, FLUOXETINE HYDROCHLORIDE (PROZAC), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and PROPRANOLOL for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Arm feels like its burning, hot) and INJECTION SITE CYST (hard knot, seems like its getting bigger Spreading down to her elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Arm feels like its burning, hot) and INJECTION SITE CYST (hard knot, seems like its getting bigger Spreading down to her elbow) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included insulin xultroph.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: L arm of injection hot to touch; L arm of injection hardness; L arm of injection itchy; L arm of injection redness; Headache; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (L arm of injection hot to touch), VACCINATION SITE INDURATION (L arm of injection hardness), VACCINATION SITE PRURITUS (L arm of injection itchy), HEADACHE (Headache) and PYREXIA (Low grade fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS and CROMOGLICATE SODIUM (CROMOLYN SOD) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced HEADACHE (Headache) and PYREXIA (Low grade fever). On 19-Mar-2021, the patient experienced VACCINATION SITE WARMTH (L arm of injection hot to touch), VACCINATION SITE INDURATION (L arm of injection hardness), VACCINATION SITE PRURITUS (L arm of injection itchy) and VACCINATION SITE ERYTHEMA (L arm of injection redness). At the time of the report, VACCINATION SITE WARMTH (L arm of injection hot to touch), VACCINATION SITE INDURATION (L arm of injection hardness), VACCINATION SITE PRURITUS (L arm of injection itchy), HEADACHE (Headache), PYREXIA (Low grade fever) and VACCINATION SITE ERYTHEMA (L arm of injection redness) outcome was unknown.            The patient did not take any treatment medication. Action taken with the mRNA-1273 in response to event is not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: L arm of injection hot to touch; L arm of injection hardness; L arm of injection itchy; L arm of injection redness; Headache; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (L arm of injection hot to touch), VACCINATION SITE INDURATION (L arm of injection hardness), VACCINATION SITE PRURITUS (L arm of injection itchy), HEADACHE (Headache) and PYREXIA (Low grade fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS and CROMOGLICATE SODIUM (CROMOLYN SOD) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced HEADACHE (Headache) and PYREXIA (Low grade fever). On 19-Mar-2021, the patient experienced VACCINATION SITE WARMTH (L arm of injection hot to touch), VACCINATION SITE INDURATION (L arm of injection hardness), VACCINATION SITE PRURITUS (L arm of injection itchy) and VACCINATION SITE ERYTHEMA (L arm of injection redness). At the time of the report, VACCINATION SITE WARMTH (L arm of injection hot to touch), VACCINATION SITE INDURATION (L arm of injection hardness), VACCINATION SITE PRURITUS (L arm of injection itchy), HEADACHE (Headache), PYREXIA (Low grade fever) and VACCINATION SITE ERYTHEMA (L arm of injection redness) outcome was unknown.            The patient did not take any treatment medication. Action taken with the mRNA-1273 in response to event is not applicable.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Skin burning sensation
Clinical narrative: Burning sensation on the arm; Headache; Nausea; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), SKIN BURNING SENSATION (Burning sensation on the arm), HEADACHE (Headache) and NAUSEA (Nausea) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Palpitations and Anaphylactic reaction since an unknown date. Concurrent medical conditions included Food allergy (Anaphylactic reaction to Sesame seed and sesame oil).    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea). On 20-Mar-2021, the patient experienced SKIN BURNING SENSATION (Burning sensation on the arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness), SKIN BURNING SENSATION (Burning sensation on the arm), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information included Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Swelling
Clinical narrative: Swelling and pain in her arm; Swelling and pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Swelling and pain in her arm) and SWELLING (Swelling and pain in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Swelling and pain in her arm) and SWELLING (Swelling and pain in her arm). At the time of the report, PAIN IN EXTREMITY (Swelling and pain in her arm) and SWELLING (Swelling and pain in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-056043 (Patient Link).   Reporter did not allow further contact
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Limb discomfort
Clinical narrative: Chills; Fever; Sinus congestion; headache; Very tired; Could not lift up arm; Arm pain up to shoulder and neck / Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired), CHILLS (Chills), PYREXIA (Fever), SINUS CONGESTION (Sinus congestion) and LIMB DISCOMFORT (Could not lift up arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for Fever.    The patient's past medical history included No adverse event. Concomitant products included LORATADINE, FEXOFENADINE, MONTELUKAST, CETIRIZINE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) 500 milligram. On 20-Mar-2021, the patient experienced FATIGUE (Very tired), LIMB DISCOMFORT (Could not lift up arm) and PAIN IN EXTREMITY (Arm pain up to shoulder and neck / Arm pain). On 21-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), SINUS CONGESTION (Sinus congestion) and HEADACHE (headache). At the time of the report, FATIGUE (Very tired), CHILLS (Chills), PYREXIA (Fever), SINUS CONGESTION (Sinus congestion), LIMB DISCOMFORT (Could not lift up arm), PAIN IN EXTREMITY (Arm pain up to shoulder and neck / Arm pain) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Body temperature: 99 (High) 99 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Sinus congestion
Clinical narrative: Chills; Fever; Sinus congestion; headache; Very tired; Could not lift up arm; Arm pain up to shoulder and neck / Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired), CHILLS (Chills), PYREXIA (Fever), SINUS CONGESTION (Sinus congestion) and LIMB DISCOMFORT (Could not lift up arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for Fever.    The patient's past medical history included No adverse event. Concomitant products included LORATADINE, FEXOFENADINE, MONTELUKAST, CETIRIZINE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) 500 milligram. On 20-Mar-2021, the patient experienced FATIGUE (Very tired), LIMB DISCOMFORT (Could not lift up arm) and PAIN IN EXTREMITY (Arm pain up to shoulder and neck / Arm pain). On 21-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), SINUS CONGESTION (Sinus congestion) and HEADACHE (headache). At the time of the report, FATIGUE (Very tired), CHILLS (Chills), PYREXIA (Fever), SINUS CONGESTION (Sinus congestion), LIMB DISCOMFORT (Could not lift up arm), PAIN IN EXTREMITY (Arm pain up to shoulder and neck / Arm pain) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Body temperature: 99 (High) 99 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity
Clinical narrative: went all the way across, halfway to her chest; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and CHEST PAIN (went all the way across, halfway to her chest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On an unknown date, the patient experienced CHEST PAIN (went all the way across, halfway to her chest). At the time of the report, PAIN IN EXTREMITY (arm pain) and CHEST PAIN (went all the way across, halfway to her chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was not provided. Patient treatment information was not provided.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received the Moderna vaccine; 16 year old received the Moderna vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of the second episode of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the Moderna vaccine) and the first episode of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the Moderna vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 043B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Obesity and Seasonal allergy. Concomitant products included IBUPROFEN (MOTRIN IB) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced the first episode of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the Moderna vaccine). On 15-Apr-2021, the patient experienced the second episode of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the Moderna vaccine). On 15-Apr-2021, last episode of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment of events was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: ADR form was received and the following information was added: Two reporters, patient race/ethnicity, medical history and Dose 2 and same event as from Dose 1. The following information was corrected from  ADR form: Patient DOB and  Dose 1 date.; Reporter's Comments: This report refers to a case of  Product administered to patient of inappropriate age for mRNA-1273, lot # unknown with no associated AEs.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough). The patient was treated with CHLORPHENAMINE MALEATE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (XL 3) ongoing since an unknown date for Cough, at a dose of 1 dosage form. At the time of the report, COUGH (cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication included XL3 for cough.  The Patient was due for her second dose of Moderna on 26-MAR-2021
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Pruritus
Clinical narrative: swelling of the throat; neck itching; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (swelling of the throat) and PRURITUS (neck itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (swelling of the throat) and PRURITUS (neck itching). At the time of the report, PHARYNGEAL SWELLING (swelling of the throat) and PRURITUS (neck itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medicines were not reported
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, Urticaria
Clinical narrative: full body rash with itching including the soles of her feet, palms of her hands, and in her ears; itching; hives; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH PRURITIC (full body rash with itching including the soles of her feet, palms of her hands, and in her ears), PRURITUS (itching) and URTICARIA (hives) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced RASH PRURITIC (full body rash with itching including the soles of her feet, palms of her hands, and in her ears), PRURITUS (itching) and URTICARIA (hives). At the time of the report, RASH PRURITIC (full body rash with itching including the soles of her feet, palms of her hands, and in her ears), PRURITUS (itching) and URTICARIA (hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.     This case was linked to MOD21-039588, MOD-2021-028455 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (tested positive for Covid-19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (tested positive). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   They had to wait 90 days after monoclonal antibodies infusion before patient can receive the 2nd dose which they are scheduling on 13Apr2021.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Redness at injection site; Warmth at injection site; swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE WARMTH (Warmth at injection site) and VACCINATION SITE SWELLING (swelling at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE WARMTH (Warmth at injection site) and VACCINATION SITE SWELLING (swelling at injection site). At the time of the report, INJECTION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE WARMTH (Warmth at injection site) and VACCINATION SITE SWELLING (swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient was taking Thyroid pill once daily. No treatment were provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Illness, Oropharyngeal pain
Clinical narrative: Had a lot of chills for a couple of night; Headache was uncomfortable; Throat didn't feel well, thought I may have the illness (Covid); I may have the illness; Nose was wetter than it had been; She reported that her breathing became more difficult and she could not control it.; chills; headache; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (chills), HEADACHE (headache), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable) and OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HEADACHE (headache).   On an unknown date, the patient experienced CHILLS (chills), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable), OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)), ILLNESS (I may have the illness), RHINORRHOEA (Nose was wetter than it had been) and DYSPNOEA (She reported that her breathing became more difficult and she could not control it.). The patient took Tylenol  to alleviate these symptoms.  she  took oxygen machine every 8 hours and  also took Advair inhaler     At the time of the report, CHILLS (chills), HEADACHE (headache), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable), OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)), ILLNESS (I may have the illness), RHINORRHOEA (Nose was wetter than it had been) and DYSPNOEA (She reported that her breathing became more difficult and she could not control it.) outcome was unknown. Not Provided        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Had a lot of chills for a couple of night; Headache was uncomfortable; Throat didn't feel well, thought I may have the illness (Covid); I may have the illness; Nose was wetter than it had been; She reported that her breathing became more difficult and she could not control it.; chills; headache; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (chills), HEADACHE (headache), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable) and OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HEADACHE (headache).   On an unknown date, the patient experienced CHILLS (chills), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable), OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)), ILLNESS (I may have the illness), RHINORRHOEA (Nose was wetter than it had been) and DYSPNOEA (She reported that her breathing became more difficult and she could not control it.). The patient took Tylenol  to alleviate these symptoms.  she  took oxygen machine every 8 hours and  also took Advair inhaler     At the time of the report, CHILLS (chills), HEADACHE (headache), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable), OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)), ILLNESS (I may have the illness), RHINORRHOEA (Nose was wetter than it had been) and DYSPNOEA (She reported that her breathing became more difficult and she could not control it.) outcome was unknown. Not Provided        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on upper thigh; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on upper thigh) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced RASH (rash on upper thigh). At the time of the report, RASH (rash on upper thigh) outcome was unknown.            Treatment Benadryl pills and cortisone cream.  Upon internal review on 24-May-2021, age was corrected to unknown.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Non-significant information received on 24-MAY-2021. Reporter's contact details obtained
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Some of the vaccine was leaked out; Some of the vaccine was leaked out; This spontaneous case was reported by a nurse and describes the occurrence of DEVICE CONNECTION ISSUE (Some of the vaccine was leaked out) and UNDERDOSE (Some of the vaccine was leaked out) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DEVICE CONNECTION ISSUE (Some of the vaccine was leaked out) and UNDERDOSE (Some of the vaccine was leaked out). On 24-Mar-2021, DEVICE CONNECTION ISSUE (Some of the vaccine was leaked out) and UNDERDOSE (Some of the vaccine was leaked out) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: slight temperature; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (slight temperature) and CHILLS (chills) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013MZ0A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (slight temperature) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PYREXIA (slight temperature) and CHILLS (chills) outcome was unknown.            patient was taking blood pressure medications and cholesterol medications.   This case was linked to MOD-2021-056157 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: already more than 42 days since their 1st Dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (already more than 42 days since their 1st Dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (already more than 42 days since their 1st Dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (already more than 42 days since their 1st Dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. /unknown.  Concomitant product use was not provided/unknown by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness
Clinical narrative: flu like symptoms; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and ARTHRALGIA (joint pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and ARTHRALGIA (joint pain). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided          Patient took concomitant medications for hormone three times a week.  Treatment information was not provided. /unknown.  Patient  wants to knew if it is okay to take Tylenol after getting vaccinated   Reporter did not allow further contact.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection, Oral herpes, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold Sore), PAIN IN EXTREMITY (sore arm) and HERPES VIRUS INFECTION (herpes outbreak) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included Cold sores (Patient experienced the first Cold Sore in 5-6 years.).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced ORAL HERPES (Cold Sore), PAIN IN EXTREMITY (sore arm) and HERPES VIRUS INFECTION (herpes outbreak). At the time of the report, ORAL HERPES (Cold Sore), PAIN IN EXTREMITY (sore arm) and HERPES VIRUS INFECTION (herpes outbreak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant medication was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: Patient attached pictures of adverse event.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered to 16 year old; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 16 year old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 16 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 16 year old) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines reported.  No treatment information were reported.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Pain in extremity, Panic attack
Clinical narrative: She could barely walk, she scrolls to move; Panic attacks; Sore arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (She could barely walk, she scrolls to move), PANIC ATTACK (Panic attacks), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included VITAMINS NOS for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). On 23-Mar-2021, the patient experienced GAIT DISTURBANCE (She could barely walk, she scrolls to move) and PANIC ATTACK (Panic attacks). At the time of the report, GAIT DISTURBANCE (She could barely walk, she scrolls to move) and PANIC ATTACK (Panic attacks) outcome was unknown and PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) had resolved.            Other concomitant medications were eyes medicine, medicine for dryness in her vagina. Quetiapine 25 mg her PCP prescribed her that for anxiety and she started taking it yesterday night.   Treatment details included none.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Hot flush, Pain in extremity, Peripheral swelling
Clinical narrative: Hot flushes like fever; Warm to touch; Lump growing bigger; Sore arm; Itchy; Swollen; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flushes like fever), FEELING HOT (Warm to touch), VACCINATION SITE MASS (Lump growing bigger), PAIN IN EXTREMITY (Sore arm) and PRURITUS (Itchy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (Hot flushes like fever), FEELING HOT (Warm to touch), VACCINATION SITE MASS (Lump growing bigger), PAIN IN EXTREMITY (Sore arm), PRURITUS (Itchy), PERIPHERAL SWELLING (Swollen) and HEADACHE (Bad headache). The patient was treated with IBUPROFEN (ADVIL HEADACHE & MIGRAINE) for Headache, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flushes like fever), FEELING HOT (Warm to touch), VACCINATION SITE MASS (Lump growing bigger), PAIN IN EXTREMITY (Sore arm), PRURITUS (Itchy), PERIPHERAL SWELLING (Swollen) and HEADACHE (Bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. /unknown.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site mass
Clinical narrative: Hot flushes like fever; Warm to touch; Lump growing bigger; Sore arm; Itchy; Swollen; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flushes like fever), FEELING HOT (Warm to touch), VACCINATION SITE MASS (Lump growing bigger), PAIN IN EXTREMITY (Sore arm) and PRURITUS (Itchy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (Hot flushes like fever), FEELING HOT (Warm to touch), VACCINATION SITE MASS (Lump growing bigger), PAIN IN EXTREMITY (Sore arm), PRURITUS (Itchy), PERIPHERAL SWELLING (Swollen) and HEADACHE (Bad headache). The patient was treated with IBUPROFEN (ADVIL HEADACHE & MIGRAINE) for Headache, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flushes like fever), FEELING HOT (Warm to touch), VACCINATION SITE MASS (Lump growing bigger), PAIN IN EXTREMITY (Sore arm), PRURITUS (Itchy), PERIPHERAL SWELLING (Swollen) and HEADACHE (Bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. /unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Condition aggravated, Product dose omission issue
Clinical narrative: Condition aggravated; past 42 days between doses; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (past 42 days between doses) and CONDITION AGGRAVATED (Condition aggravated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (past 42 days between doses). On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition aggravated). At the time of the report, PRODUCT DOSE OMISSION ISSUE (past 42 days between doses) and CONDITION AGGRAVATED (Condition aggravated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. /unknown.  Concomitant product use was not provided/unknown by the reporter.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Inappropriate age for Vaccine Administration; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration). On 15-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Mass, Musculoskeletal stiffness, Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of musculoskeletal stiffness, mass (too many bumps), rash (rash on the back of the neck), rash (rash on the chest) and rash (rash on the face) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced musculoskeletal stiffness, mass (too many bumps), rash (has a rash on the back of the neck), rash (rash on the chest), rash (rash on the face) and chills. At the time of the report, musculoskeletal stiffness, mass (too many bumps), rash (rash on the back of the neck), rash (rash on the chest), rash (rash on the face) and chills outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported. Reporter did not allow further contact.